Immorta Bio

2/10Traction

Immorta Bio develops personalized regenerative therapies using autologous pluripotent stem cells to create young, patient-specific progenitor cells for organ rejuvenation and immune enhancement. The company targets diseases of aging, including cancer and organ failure, by addressing the underlying cellular deterioration associated with aging.

Miami Beach, United States · HQ

Founded 20235100+ followers

Biotechnology

Updated 5 months ago

Funding

Funding rounds are not available yet.

Founders

3 founders

Boris Reznik

CEO

Yuri Kaplun

Entrepreneur

Thomas Ichim

CSO

Product

Features

Immorta Bio develops personalized regenerative therapies using autologous pluripotent stem cells to create young, patient-specific progenitor cells for organ rejuvenation and immune enhancement. The company targets diseases of aging, including cancer and organ failure, by addressing the underlying cellular deterioration associated with aging.